Mining FDA drug labels using an unsupervised learning technique--topic modeling

scientific article

Mining FDA drug labels using an unsupervised learning technique--topic modeling is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/bmcbi/BisginLFXT11
P6179Dimensions Publication ID1017224302
P356DOI10.1186/1471-2105-12-S10-S11
P932PMC publication ID3236833
P698PubMed publication ID22166012

P50authorWeida TongQ96475222
P2093author name stringHong Fang
Zhichao Liu
Xiaowei Xu
Halil Bisgin
P2860cites workOnline Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disordersQ24558589
Timing of new black box warnings and withdrawals for prescription medicationsQ28216033
Finding complex biological relationships in recent PubMed articles using Bio-LDAQ28477467
Extraction of semantic biomedical relations from text using conditional random fieldsQ28754563
Identifying biological concepts from a protein-related corpus with a probabilistic topic modelQ33233422
Using the literature-based discovery paradigm to investigate drug mechanismsQ33359167
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.Q34010718
What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labelingQ35837119
"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/riskQ36357738
Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning systemQ37743401
Mapping adverse drug reactions in chemical space.Q39881783
Fish oil, Raynaud's syndrome, and undiscovered public knowledgeQ69703977
How adverse drug reactions can play a role in innovative drug researchQ70992416
P921main subjectunsupervised learningQ1152135
topic modelQ3532085
Topic modelingQ96468792
P304page(s)S11
P577publication date2011-10-18
P1433published inBMC BioinformaticsQ4835939
P1476titleMining FDA drug labels using an unsupervised learning technique--topic modeling
P478volume12 Suppl 10

Reverse relations

cites work (P2860)
Q34062615A phenome-guided drug repositioning through a latent variable model
Q110949995A systematic review on literature-based discovery workflow
Q35051254A systems approach for analysis of high content screening assay data with topic modeling
Q28078205An overview of topic modeling and its current applications in bioinformatics
Q92656083Artificial Intelligence in Anesthesiology: Current Techniques, Clinical Applications, and Limitations
Q35596642Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials
Q64940658Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches.
Q36906830Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records.
Q35569693Discovering associations among diagnosis groups using topic modeling
Q40098361FINDING POTENTIALLY UNSAFE NUTRITIONAL SUPPLEMENTS FROM USER REVIEWS WITH TOPIC MODELING.
Q45945293Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models.
Q38608709From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources
Q38209986Integrative approaches for predicting in vivo effects of chemicals from their structural descriptors and the results of short-term biological assays
Q34436688Investigating drug repositioning opportunities in FDA drug labels through topic modeling
Q36170276Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams
Q47219850Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling
Q34686845Mining FDA drug labels for medical conditions
Q35005256Mining hidden knowledge for drug safety assessment: topic modeling of LiverTox as a case study
Q30573306Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases
Q34538839Of text and gene--using text mining methods to uncover hidden knowledge in toxicogenomics
Q36853573Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network
Q34099736Proceedings of the 2011 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) conference. Introduction
Q34436560Proceedings of the 2012 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) conference. Introduction.
Q55963652Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases
Q34549552Redundancy in electronic health record corpora: analysis, impact on text mining performance and mitigation strategies
Q35097259Redundancy-aware topic modeling for patient record notes
Q35097852Semantic processing to identify adverse drug event information from black box warnings
Q55645213Semantic processing to identify adverse drug event information from black box warnings.
Q64091947Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
Q48158859Systematic identification of latent disease-gene associations from PubMed articles
Q35963529Text mining for identifying topics in the literatures about adolescent substance use and depression
Q51429997Topic Modeling of Smoking- and Cessation-Related Posts to the American Cancer Society's Cancer Survivor Network (CSN): Implications for Cessation Treatment for Cancer Survivors Who Smoke.
Q38187450Toward predictive models for drug-induced liver injury in humans: are we there yet?
Q89782267Whole-Genome k-mer Topic Modeling AssociatesBacterial Families

Search more.